Insception

Mississauga, Canada Founded: 1996 • Age: 30 yrs Acquired By Generate
Largest cord blood program in Canada
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Insception

Insception is a company based in Mississauga (Canada) founded in 1996 was acquired by Generate in June 2021. Insception operates in a competitive market with competitors including GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.

  • Headquarter Mississauga, Canada
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $4.5 M (USD), Debt – Venture

    Sep 28, 2012

  • Investors
  • Employee Count
    Not available
  • Acquired by
    Generate

    & 1 more

    (Jun 02, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Insception

Investors in Insception

Insception has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Wellington Financial, Generate and MMV Financial.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Tech-focused Venture debt provider investing primarily in the US and Canada
Locked Locked Locked
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America
Locked Locked Locked
Private equity fund that buys shares and helps grow owner-managed businesses.
Locked Locked Locked
Premium access

Investor details for Insception

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Insception

Investments
Premium access

Investment portfolio details for Insception

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Insception

Premium access

Detailed financials for Insception

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Insception Comparisons

Insception Primary company
Description
Largest cord blood program in Canada
Location
Mississauga, Canada
Founded Year
1996
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Insception

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Insception

Insception operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
Locked Locked Locked
Provider of a biorepository of human clinical specimens
Locked Locked Locked
Biospecimens are collected, preserved, and analyzed for oncology services.
Locked Locked Locked
Provider of services for collecting and preserving umbilical cord blood stem cells
Locked Locked Locked
Provides bio repository services
Locked Locked Locked
A blockchain-based platform for tokenizing and incentivizing stem cell donations
Premium access

Detailed competitors of Insception

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Insception

Premium access

Complete news archive for Insception

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Insception

Insception was founded in 1996 and raised its 1st funding round 10 years after it was founded.

Insception is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.

Insception was founded in 1996 and is based in Mississauga, Canada, within the healthcare sector focused on cord blood banking. Over 39,000 units have been collected, processed, and stored through partnerships with facilities like Mount Sinai Hospital and Scarborough Hospital. Ownership is held by Argosy Partners, Mount Sinai Hospital, management, and scientific founders. Services include secure processing, long-term storage, and governance for Canadian families.

Insception's top competitors include iSpecimen, AminoChain and GenVault Corporation.

Insception has 4 investors. Key investors include Wellington Financial, Generate, MMV Financial, and The Succession Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available